Clinical Trial Update: Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating oxaliplatin plus capecitabine as neoadjuvant chemotherapy for locally advanced colon cancer, with results on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Cancer | Phase 2 | Status: UNKNOWN